GREAT ELM GROUP INC (GEG)

US39037G1094 - Common Stock

1.85  -0.03 (-1.6%)

Fundamental Rating

4

GEG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 117 industry peers in the Health Care Providers & Services industry. While GEG seems to be doing ok healthwise, there are quite some concerns on its profitability. GEG is not valued too expensively and it also shows a decent growth rate.



Quickly go to:

3

1. Profitability

1.1 Basic Checks

GEG had positive earnings in the past year.
GEG had a negative operating cash flow in the past year.
GEG had negative earnings in 4 of the past 5 years.
Of the past 5 years GEG 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 6.05%, GEG belongs to the top of the industry, outperforming 85.34% of the companies in the same industry.
GEG's Return On Equity of 13.09% is amongst the best of the industry. GEG outperforms 81.90% of its industry peers.
Industry RankSector Rank
ROA 6.05%
ROE 13.09%
ROIC N/A
ROA(3y)2.34%
ROA(5y)-0.25%
ROE(3y)-5.99%
ROE(5y)-8.82%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GEG's Profit Margin of 80.32% is amongst the best of the industry. GEG outperforms 99.14% of its industry peers.
GEG does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 80.32%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

4

2. Health

2.1 Basic Checks

GEG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GEG has been increased compared to 1 year ago.
The number of shares outstanding for GEG has been increased compared to 5 years ago.
GEG has a better debt/assets ratio than last year.

2.2 Solvency

GEG has an Altman-Z score of -29.78. This is a bad value and indicates that GEG is not financially healthy and even has some risk of bankruptcy.
GEG has a Altman-Z score of -29.78. This is amonst the worse of the industry: GEG underperforms 90.52% of its industry peers.
A Debt/Equity ratio of 0.95 indicates that GEG is somewhat dependend on debt financing.
GEG's Debt to Equity ratio of 0.95 is on the low side compared to the rest of the industry. GEG is outperformed by 60.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Altman-Z -29.78
ROIC/WACCN/A
WACC6.76%

2.3 Liquidity

GEG has a Current Ratio of 19.51. This indicates that GEG is financially healthy and has no problem in meeting its short term obligations.
GEG's Current ratio of 19.51 is amongst the best of the industry. GEG outperforms 100.00% of its industry peers.
GEG has a Quick Ratio of 19.51. This indicates that GEG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 19.51, GEG belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 19.51
Quick Ratio 19.51

More info and screens

4

3. Growth

3.1 Past

GEG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 266.67%, which is quite impressive.
The Revenue has grown by 74.90% in the past year. This is a very strong growth!
GEG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.08% yearly.
EPS 1Y (TTM)266.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-102.08%
Revenue 1Y (TTM)74.9%
Revenue growth 3Y-47.17%
Revenue growth 5Y8.08%
Revenue growth Q2Q48.37%

3.2 Future

Based on estimates for the next years, GEG will show a decrease in Earnings Per Share. The EPS will decrease by -1.85% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-5.24%
EPS Next 2Y-1.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.29, the valuation of GEG can be described as very cheap.
98.28% of the companies in the same industry are more expensive than GEG, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 24.95. GEG is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 1.15, the valuation of GEG can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GEG indicates a rather cheap valuation: GEG is cheaper than 99.14% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of GEG to the average of the S&P500 Index (21.40), we can say GEG is valued rather cheaply.
Industry RankSector Rank
PE 5.29
Fwd PE 1.15

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.85%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GEG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREAT ELM GROUP INC

NASDAQ:GEG (4/22/2024, 7:03:45 PM)

1.85

-0.03 (-1.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap58.52M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 5.29
Fwd PE 1.15
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.05%
ROE 13.09%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 80.32%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 19.51
Quick Ratio 19.51
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)266.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-5.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)74.9%
Revenue growth 3Y-47.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y